• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intracerebral hemorrhage in a patient receiving combination therapy of pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.

作者信息

Nishiofuku Mariko, Tsujimoto Tatsuhiro, Matsumura Yoshinobu, Toyohara Masahisa, Yoshiji Hitoshi, Yamao Jun-Ichi, Fukui Hiroshi, Yoshikawa Masahide

机构信息

Department of Gastroenterology, Ishinkai Yao General Hospital, Yao.

出版信息

Intern Med. 2006;45(7):483-4. doi: 10.2169/internalmedicine.45.1685. Epub 2006 May 1.

DOI:10.2169/internalmedicine.45.1685
PMID:16679707
Abstract
摘要

相似文献

1
Intracerebral hemorrhage in a patient receiving combination therapy of pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.一名接受聚乙二醇化干扰素α-2b与利巴韦林联合治疗慢性丙型肝炎的患者发生脑出血。
Intern Med. 2006;45(7):483-4. doi: 10.2169/internalmedicine.45.1685. Epub 2006 May 1.
2
A chronic subdural hematoma in a patient receiving combination therapy with pegylated interferon alfa-2b and ribavirin for chronic hepatitis C.一名接受聚乙二醇化干扰素α-2b和利巴韦林联合治疗慢性丙型肝炎的患者发生慢性硬膜下血肿。
Intern Med. 2013;52(18):2057-60. doi: 10.2169/internalmedicine.52.0791.
3
Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.聚乙二醇干扰素 α-2b 和利巴韦林联合治疗与聚乙二醇干扰素单药治疗在血液透析患者中的疗效和安全性：2 个连续治疗队列的比较。
Am J Kidney Dis. 2013 Oct;62(4):789-95. doi: 10.1053/j.ajkd.2013.03.037. Epub 2013 Jun 5.
4
Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.
Indian J Gastroenterol. 2011 Sep;30(5):239-40. doi: 10.1007/s12664-011-0126-4.
5
Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.聚乙二醇化干扰素α-2b联合利巴韦林治疗慢性丙型肝炎病毒患者时出现的皮肤不良反应
J Dermatol. 2007 Aug;34(8):577-82. doi: 10.1111/j.1346-8138.2007.00336.x.
6
Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence.
Gastroenterology. 2003 Jun;124(7):2003-4; author reply 2004-5. doi: 10.1016/s0016-5085(03)00576-6.
7
Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.慢性丙型肝炎病毒患者接受干扰素α-2b联合利巴韦林治疗后的皮肤不良反应
Acta Derm Venereol. 2001 Jun-Jul;81(3):223. doi: 10.1080/000155501750376447.
8
Summaries for patients. Duration and dose of antiviral treatment for chronic hepatitis C.患者摘要。慢性丙型肝炎抗病毒治疗的疗程和剂量。
Ann Intern Med. 2004 Mar 2;140(5):I67. doi: 10.7326/0003-4819-140-5-200403020-00004.
9
Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin.聚乙二醇化干扰素α-2b加利巴韦林相关的纯红细胞再生障碍性贫血
Am J Hematol. 2008 Sep;83(9):758-9. doi: 10.1002/ajh.21229.
10
Side effects of therapy for chronic hepatitis C.慢性丙型肝炎治疗的副作用
Gastroenterology. 2003 May;124(6):1711-9. doi: 10.1016/s0016-5085(03)00394-9.

引用本文的文献

1
Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.竞争偏倚对信号产生的影响：法国自发报告研究数据库分析。
Drug Saf. 2012 Oct 1;35(10):855-64. doi: 10.1007/BF03261981.
2
SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group.滑膜肉瘤患者的 SYT-SSX 断点肽疫苗：日本肌肉骨骼肿瘤学组的研究。
Cancer Sci. 2012 Sep;103(9):1625-30. doi: 10.1111/j.1349-7006.2012.02370.x. Epub 2012 Aug 7.